» Articles » PMID: 39562714

Hospitalizations and Deaths Among People Coinfected with HIV and HCV

Overview
Journal Sci Rep
Specialty Science
Date 2024 Nov 20
PMID 39562714
Authors
Affiliations
Soon will be listed here.
Abstract

Coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) remains a significant public health challenge. This retrospective, population-based study assessed the trends in hospitalization rates among patients co-infected with HCV and HIV in Poland in 2012-2022, encompassing the COVID-19 pandemic and massive influx of war refugees from Ukraine, the demographics and clinical characteristics among hospitalized patients, including in-hospital case fatality rates. Most hospitalized patients were over 40 years old (mean ± SD: 41.7 ± 8.9 years) and were men (74%). The mean annual hospitalization rate was estimated at 1.33 per 10 and was three-fold lower in the pandemic period (mean 0.51 per 10) than in the pre-pandemic era (mean 1.63 per 10). In turn, the in-hospital case-fatality rates increased during the pandemic in men (from a mean of 1.83 to 3.93) but not in women (a mean of 1.53 in both periods). There was no significant increase in hospitalization rates in 2022, during which the significant inflow of war refugees in Ukraine occurred. The epidemiological situation of people (co)infected with HIV and HCV in Poland requires further monitoring, though it did not escalate in the studied period due to the influx of war refugees from Ukraine.

Citing Articles

Bistability and bifurcations in HIV-1 infection model with non-monotone responses.

Pradeesh M, Mani P Sci Rep. 2025; 15(1):7265.

PMID: 40025097 PMC: 11873265. DOI: 10.1038/s41598-025-91417-x.


Drug-Drug Interactions Between HIV Antivirals and Concomitant Drugs in HIV Patients: What We Know and What We Need to Know.

De Bellis E, Donnarumma D, Zarrella A, Mazzeo S, Pagano A, Manzo V Pharmaceutics. 2025; 17(1).

PMID: 39861680 PMC: 11768951. DOI: 10.3390/pharmaceutics17010031.

References
1.
Genowska A, Zarebska-Michaluk D, Strukcinskiene B, Razbadauskas A, Moniuszko-Malinowska A, Jurgaitis J . Changing Epidemiological Patterns of Infection and Mortality Due to Hepatitis C Virus in Poland. J Clin Med. 2023; 12(12). PMC: 10299469. DOI: 10.3390/jcm12123922. View

2.
Schnuriger A, Dominguez S, Valantin M, Tubiana R, Duvivier C, Ghosn J . Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals. J Clin Microbiol. 2006; 44(4):1561-3. PMC: 1448659. DOI: 10.1128/JCM.44.4.1561-1563.2006. View

3.
Jin F, Dore G, Matthews G, Luhmann N, Macdonald V, Bajis S . Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020; 6(1):39-56. DOI: 10.1016/S2468-1253(20)30303-4. View

4.
. EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020; 73(5):1170-1218. DOI: 10.1016/j.jhep.2020.08.018. View

5.
van de Klundert M, Antonova A, Di Teodoro G, Cena Diez R, Chkhartishvili N, Heger E . Molecular Epidemiology of HIV-1 in Eastern Europe and Russia. Viruses. 2022; 14(10). PMC: 9609922. DOI: 10.3390/v14102099. View